Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Bayer (BAYN.DE) has a market cap of $23.13 billion USD. According to our data, Bayer is ranked No.825 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $23.13 B |
7.82%
|
| Dec 30, 2024 | $21.45 B |
-42.34%
|
| Dec 29, 2023 | $37.19 B |
-27.50%
|
| Dec 30, 2022 | $51.30 B |
6.20%
|
| Dec 30, 2021 | $48.31 B |
1.34%
|
| Dec 30, 2020 | $47.67 B |
-30.79%
|
| Dec 30, 2019 | $68.88 B |
25.96%
|
| Dec 28, 2018 | $54.68 B |
-39.17%
|
| Dec 29, 2017 | $89.89 B |
7.47%
|
| Dec 30, 2016 | $83.65 B |
-12.22%
|
| Dec 30, 2015 | $95.29 B |
4.19%
|
| Dec 30, 2014 | $91.46 B |
13.18%
|
| Dec 30, 2013 | $80.81 B |
45.21%
|
| Dec 28, 2012 | $55.65 B |
49.97%
|
| Dec 30, 2011 | $37.10 B |
-8.35%
|
| Dec 30, 2010 | $40.49 B |
1.78%
|
| Dec 30, 2009 | $39.78 B |
39.79%
|
| Dec 30, 2008 | $28.45 B |
-31.89%
|
| Dec 28, 2007 | $41.78 B |
56.87%
|
| Dec 29, 2006 | $26.63 B |
18.29%
|
| Dec 30, 2005 | $22.51 B |
44.64%
|
| Dec 31, 2004 | $15.57 B |
9.82%
|
| Dec 31, 2003 | $14.17 B |
19.99%
|
| Dec 31, 2002 | $11.81 B |
-41.46%
|
| Dec 31, 2001 | $20.18 B |
-33.99%
|
| Dec 29, 2000 | $30.57 B |
24.60%
|
| Dec 31, 1999 | $24.53 B |
28.69%
|
| Dec 31, 1998 | $19.06 B |
5.32%
|
| Dec 31, 1997 | $18.10 B |
5.71%
|
| Dec 31, 1996 | $17.12 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
 Takeda Pharmaceutical
TAK
|
$45.76 B |
0.002 M
|
Japan
|
 Novo Nordisk
NVO
|
$286.98 B |
70.023 B
|
Denmark
|
| Market Cap | = | BAYN.DE Stock Price | * | BAYN.DE Shares Outstanding |
| = | $23.54 | * | 0.98 B | |
| = | $23.13 B |